WallStSmart

Circle Internet Group, Inc. (CRCL)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

West Pharmaceutical Services Inc generates 17% more annual revenue ($3.22B vs $2.75B). WST leads profitability with a 16.9% profit margin vs -2.5%. WST appears more attractively valued with a PEG of 2.89. WST earns a higher WallStSmart Score of 67/100 (B-).

CRCL

Hold

42

out of 100

Grade: D

Growth: 10.0Profit: 3.0Value: 4.0Quality: 5.0
Piotroski: 2/9Altman Z: 0.05

WST

Strong Buy

67

out of 100

Grade: B-

Growth: 7.3Profit: 8.0Value: 2.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CRCL.

WSTSignificantly Overvalued (-32.4%)

Margin of Safety

-32.4%

Fair Value

$185.95

Current Price

$325.92

$139.97 premium

UndervaluedFair: $185.95Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRCL3 strengths · Avg: 10.0/10
Revenue GrowthGrowth
76.9%10/10

Revenue surging 76.9% year-over-year

EPS GrowthGrowth
880.0%10/10

Earnings expanding 880.0% YoY

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

WST4 strengths · Avg: 9.0/10
EPS GrowthGrowth
56.1%10/10

Earnings expanding 56.1% YoY

Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.7%8/10

Strong operational efficiency at 21.7%

Revenue GrowthGrowth
21.0%8/10

Revenue surging 21.0% year-over-year

Areas to Watch

CRCL4 concerns · Avg: 2.8/10
Price/BookValuation
8.3x4/10

Trading at 8.3x book value

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
4.352/10

Expensive relative to growth rate

Return on EquityProfitability
-2.8%2/10

ROE of -2.8% — below average capital efficiency

WST2 concerns · Avg: 2.0/10
PEG RatioValuation
2.892/10

Expensive relative to growth rate

P/E RatioValuation
41.8x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CRCL

The strongest argument for CRCL centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 76.9% demonstrates continued momentum.

Bull Case : WST

The strongest argument for WST centers on EPS Growth, Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.9% and operating margin at 21.7%. Revenue growth of 21.0% demonstrates continued momentum.

Bear Case : CRCL

The primary concerns for CRCL are Price/Book, Piotroski F-Score, PEG Ratio.

Bear Case : WST

The primary concerns for WST are PEG Ratio, P/E Ratio. A P/E of 41.8x leaves little room for execution misses.

Key Dynamics to Monitor

CRCL profiles as a hypergrowth stock while WST is a growth play — different risk/reward profiles.

CRCL is growing revenue faster at 76.9% — sustainability is the question.

CRCL generates stronger free cash flow (233M), providing more financial flexibility.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WST scores higher overall (67/100 vs 42/100), backed by strong 16.9% margins and 21.0% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Circle Internet Group, Inc.

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Circle Internet Group, Inc. is a platform, network, and market infrastructure for stablecoin and blockchain applications. The company is headquartered in New York, New York.

Visit Website →

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?